Quipt Home Medical (NASDAQ:QIPT) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Quipt Home Medical (NASDAQ:QIPT) was given a new $3.65 price target on by analysts at Canaccord Genuity Group Inc..
Quipt Home Medical (NASDAQ:QIPT) had its "hold" rating reaffirmed by analysts at Canaccord Genuity Group Inc..
Quipt Home Medical (NASDAQ:QIPT) was downgraded by analysts at Stifel Canada from a "strong-buy" rating to a "strong sell" rating.
Quipt Home Medical (NASDAQ:QIPT) had its "buy" rating reaffirmed by analysts at Benchmark Co..